Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Marker Chromosomes Are a New Cytogenetic Adverse Risk Factor in AML after Allo-HCT

Kyoko Fuse, MD, Tomoyuki Tanaka, MD PhD, Shun Uemura, MD, Tatsuya Suwabe, MD, Takayuki Katagiri, MD, Takashi Ushiki, MD PhD, Yasuhiko Shibasaki, MD, Naoko Sato, MD PhD, Toshio Yano, MD PhD, Takashi Kuroha, MD PhD, Shigeo Hashimoto, MD PhD, Tastuo Furukawa, MD PhD, Miwako Narita, MD PhD, Hirohito Sone, MD PhD, Masayoshi Masuko, MD PhD

Blood (2018) 132 (Supplement 1): 5260.

https://doi.org/10.1182/blood-2018-99-113251

Published: 2018

Journal Articles

Patient-Based Prediction Algorithm of Relapse after Allo-HSCT for Acute Leukemia Using Machine Learning Approach

Kyoko Fuse, MD, Shun Uemura, MD, Tatsuya Suwabe, MD, Takayuki Katagiri, MD, Tomoyuki Tanaka, MD, Takashi Ushiki, MD PhD, Yasuhiko Shibasaki, MD PhD, Naoko Sato, MD PhD, Toshio Yano, MD PhD, Takashi Kuroha, MD PhD, Shigeo Hashimoto, MD PhD, Tastuo Furukawa, MD PhD, Miwako Narita, MD PhD, Hirohito Sone, MD PhD, Masayoshi Masuko, MD PhD

Blood (2017) 130 (Supplement 1): 2044.

https://doi.org/10.1182/blood.V130.Suppl_1.2044.2044

Published: 2017

Journal Articles

The Predictive Factors of Favorable Prognosis after Allo-HSCT for Refractory Acute Leukemia

Kyoko Fuse, MD, Takayuki Katagiri, MD, Yasuhiko Shibasaki, MD PhD, Tomoyuki Tanaka, MD, Miwako Narita, MD PhD, Hirohito Sone, MD PhD, Masayoshi Masuko, MD PhD, Tatsuo Furukawa, MD PhD, Naoko Sato, MD PhD, Toshio Yano, MD PhD, Takashi Kuroha, MD PhD, Shigeo Hashimoto, MD PhD, Takashi Ushiki, MD PhD

Blood (2016) 128 (22): 2297.

https://doi.org/10.1182/blood.V128.22.2297.2297

Published: 2016

Journal Articles

Enhancing Effects of Heparin/Low Molecular Weight Heparin/Heparan Sulfate on Antigen Presentation and Antigen-Specific Cytotoxic T Lymphocyte (CTL) Induction by Monocyte-Derived Dendritic Cells.

Asuka Sekiguchi, Miwako Narita, MD, Toshio Yano, MD, Naoko Sato, MD, Anri Saito, Norihiro Watanabe, Ayumi Yokoyama, Flavio Ayres, PhD, Louie Alldawi, MD, Tatsuo Furukawa, MD, Ken Toba, MD, Yoko Watanabe, Yoshiaki Takahashi, PhD, Masuhiro Takahashi, MD

Blood (2004) 104 (11): 3816.

https://doi.org/10.1182/blood.V104.11.3816.3816

Published: 2004

Journal Articles

Generation of Antigen Specific Cytotoxic T Lymphocytes (CTL) by Dendritic Cells (DCs) Transfected with In Vitro Transcribed (IVT) SART-1 and WT-1 mRNA.

Anri Saito, Miwako Narita, MD, Toshio Yano, MD, Naoko Sato, MD, Asuka Sekiguchi, Norihiro Watanabe, Ayumi Yokoyama, Flavio Ayres, PhD, Louie Alldawi, Tatsuo Furukawa, MD, Ken Toba, MD, Yoko Watanabe, Yoshiaki Takahashi, PhD, Masuhiro Takahashi, MD

Blood (2004) 104 (11): 3859.

https://doi.org/10.1182/blood.V104.11.3859.3859

Published: 2004

Journal Articles

Enhancing Effects of CCL19 on Antigen Uptake and Antigen Presenting Ability of Human Mature Dendritic Cells (DCs).

Ayumi Yokoyama, Miwako Narita, Naoko Sato, Asuka Sekiguchi, Anri Saito, Norihiro Watanabe, Masuhiro Takahashi

Blood (2004) 104 (11): 3830.

https://doi.org/10.1182/blood.V104.11.3830.3830

Published: 2004

Journal Articles

Bestowing Transient Cytotoxic Capability on Dendritic Cells by Transfection with In Vitro Transcribed (IVT) TRAIL mRNA.

Norihiro Watanabe, Miwako Narita, MD, Toshio Yano, MD, Naoko Sato, MD, Asuka Sekiguchi, Anri Saito, Ayumi Yokoyama, Flavio Ayres, PhD, Louie Alldawi, MD, Tatsuo Furukawa, MD, Ken Toba, MD, Yoko Watanabe, Yoshiaki Takahashi, PhD, Masuhiro Takahashi, MD

Blood (2004) 104 (11): 5282.

https://doi.org/10.1182/blood.V104.11.5282.5282

Published: 2004

NARROW

Marker Chromosomes Are a New Cytogenetic Adverse Risk Factor in AML after Allo-HCT

Patient-Based Prediction Algorithm of Relapse after Allo-HSCT for Acute Leukemia Using Machine Learning Approach

The Predictive Factors of Favorable Prognosis after Allo-HSCT for Refractory Acute Leukemia

Enhancing Effects of Heparin/Low Molecular Weight Heparin/Heparan Sulfate on Antigen Presentation and Antigen-Specific Cytotoxic T Lymphocyte (CTL) Induction by Monocyte-Derived Dendritic Cells.

Generation of Antigen Specific Cytotoxic T Lymphocytes (CTL) by Dendritic Cells (DCs) Transfected with In Vitro Transcribed (IVT) SART-1 and WT-1 mRNA.

Enhancing Effects of CCL19 on Antigen Uptake and Antigen Presenting Ability of Human Mature Dendritic Cells (DCs).

Bestowing Transient Cytotoxic Capability on Dendritic Cells by Transfection with In Vitro Transcribed (IVT) TRAIL mRNA.

Email alerts

ASH Publications

American Society of Hematology

Marker Chromosomes Are a New Cytogenetic Adverse Risk Factor in AML after Allo-HCT

Patient-Based Prediction Algorithm of Relapse after Allo-HSCT for Acute Leukemia Using Machine Learning Approach

The Predictive Factors of Favorable Prognosis after Allo-HSCT for Refractory Acute Leukemia

Enhancing Effects of Heparin/Low Molecular Weight Heparin/Heparan Sulfate on Antigen Presentation and Antigen-Specific Cytotoxic T Lymphocyte (CTL) Induction by Monocyte-Derived Dendritic Cells.

Generation of Antigen Specific Cytotoxic T Lymphocytes (CTL) by Dendritic Cells (DCs) Transfected with In Vitro Transcribed (IVT) SART-1 and WT-1 mRNA.

Enhancing Effects of CCL19 on Antigen Uptake and Antigen Presenting Ability of Human Mature Dendritic Cells (DCs).

Bestowing Transient Cytotoxic Capability on Dendritic Cells by Transfection with In Vitro Transcribed (IVT) TRAIL mRNA.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only